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                                        ABSTRACT 
Title: Correlation between Pulse Pressure Variation (PPV) and adequacy of intra-vascular 
volume as reflected by time to urine output in renal transplant recipients 
Department: Department of Anaesthesiology, Christian Medical College, Vellore 
Name of Candidate: Y. Bernice Theodore 
Degree and Subject: MD Anaesthesiology  
Name of Guide: Tony Thomson Chandy 
Objectives 
1. To determine a correlation between PPV at the time of graft revascularization and Time to 
urine output 
2. To determine the best target PPV to achieve early post transplant diuresis 
 
Methods:  33 adult patients undergoing elective renal transplantation were studied. 
Intravascular volume was maintained with intravenous fluids, targeting a CVP of 10-15 mm 
of Hg. PPV was also monitored but not used to influence fluid management. Both CVP and 
PPV were monitored continuously and recorded every 15 minutes. The values measured at 
the time of release of the vascular cross clamps were assumed to indicate the situation at 
the time of graft reperfusion. The outcome measure used to assess intravascular volume 
was time to urine output following reperfusion in seconds (TUO). It was considered 
desirable for time to urine output to be ≤ 120 seconds.  
Results and Conclusions:  It was found that PPV did not have a linear correlation with 
time to urine output. ROC analysis revealed that the most appropriate cut off to use was < 
10%. In patients whose PPV value was > 10%, 83.33% had a time to urine output of over 120 
seconds. Therefore it could be used as a parameter to monitor the state of intravascular 
volume and aid in intra-operative fluid management of patients undergoing renal 
transplantation.  
 
Key words 
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INTRODUCTION 
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Chronic kidney disease is a growing health problem worldwide and so too in 
India with the rising incidence of the following risk factors namely Diabetes Mellitus and 
Hypertension. A proportion of these patients will go on to develop end stage disease 
and will require dialysis and some will eventually require renal transplantation.    
 
Long term graft survival depends on multiple factors. Early graft dysfunction and 
delayed graft dysfunction has been attributed to graft perfusion. While graft reperfusion 
is dependent on multiple contributors of the cardiovascular system, maintenance of the 
intravascular volume remains the key role of the anaesthetists. 
 
Patients with end stage renal disease, awaiting renal transplant are usually on 
haemodialysis. Perl-operative dialysis has improved biochemical abnormalities and fluid 
overload status and hence improved postoperative outcomes.  
 
However, in the peri-operative periods intravascular depletion occurs. Early 
correction and maintenance of this fluid depletion is important for adequate perfusion of 
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the organ both at the time of the revascularization and also for the long term function of 
the graft organ. Though a surrogate marker, an immediate indicator of adequate 
function of the renal graft is reflected as post operative urine output.  
 
Often in the peri-operative period, intravascular volume is measured by 
assessing hemodynamic parameters such as central venous pressure (CVP). CVP is 
considered the gold standard measure in renal transplant recipients as it has been in 
use for many years. The targeted CVP for patients undergoing renal transplantation is 
10-15 mm Hg (11).  
 
Newer parameters, namely pulse pressure variation (PPV) and stroke volume 
variation (SVV) are dynamic parameters and therefore in theory superior to CVP in 
assessing intravascular volume. Though it has become possible to measure these 
parameters real time with new anaesthetic monitors, CVP remains the most widely used 
parameter as its value is proven and the accuracy of PPV has not been assessed 
adequately in various clinical scenarios.  
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This study examines the value of PPV in assessing intravascular volume as 
reflected by time to first urine output and total urine volume in the first 4 hours. 
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AIM AND OBJECTIVES 
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AIM 
To determine a correlation between pulse pressure variation (PPV) and intravascular 
volume as reflected by onset time of graft diuresis in renal transplant recipients.  
 
OBJECTIVES 
1. To determine a correlation between PPV at the time of graft revascularization 
and Time to urine output 
2. To determine the best target PPV to achieve early post transplant diuresis 
 
HYPOTHESIS 
Pulse pressure variation (PPV) is a useful measure of adequacy of the intravascular 
volume in patients undergoing renal transplant. 
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REVIEW OF LITERATURE 
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CHRONIC KIDNEY DISEASE / END STAGE RENAL DISEASE 
 
By definition, Chronic kidney disease (CKD) the presence of kidney damage or a 
decrease in renal function, for a duration of at least three.  
 
There are five stages of chronic kidney disease as per the guidelines of the 
National Kidney Foundation, Kidney Disease Outcomes Quality Initiative depending on 
how severe the damage is to the kidneys, or the level of decrease in kidney function. 
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EPIDEMIOLOGY 
 
 
The incidence of Chronic kidney disease (CKD) is on the increase worldwide. (2). 
The growing incidence of diabetes mellitus (3) and hypertension (4,5) could account for 
this. These trends are likely to be observed in India as well.  It has been difficult to 
estimate the true numbers of patients with CKD and ESRD in India without a 
comprehensive national CKD registry.  A voluntary online registry (www.ckdri.org) 
reflects only a small fraction of the total number of CKD patients in India. Workers in this 
field have reported that the incidence of ESRD in India is approximately 229 per million 
(6), and >100,000 new patients enter become dependent on dialysis every year (7). 
Reports from the SEEK (Screening and Early Evaluation of Kidney Disease) study 
showed that in their cohort of 5588 subjects the prevalence of CKD in India was 17.2% 
with approximately 1% of these having stage 5 disease (ESRD) (8). 
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APPROACH TO TREATMENT 
 
The management of chronic kidney disease is basically to diagnose the disease 
early and evaluate for the underlying causes and treat it when possible. Appropriate 
preventive measures usually delay the progression and in some situations even halt 
disease. There are three components of treatment that should be instituted 
simultaneously.  
 
These are 
1. Measures to delay or halt progression. 
2. Addressing the secondary manifestations 
3. Planning of renal replacement therapy 
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Measures to delay or halt disease progression 
• Evaluation and treatment of the underlying condition when possible 
• Control of Hypertension 
• Control of Diabetes target HbA1C< 7% 
• Treatment of Hyperlipidemia  
• Avoidance of nephrotoxins – drugs and IV contrast 
• Blocking the renin-angiotensin axis blockers in patients with diabetic nephropathy 
 
The secondary pathologic manifestations of CKD that need to be managed are: 
• Anemia: erythropoiesis-stimulating agents  
• Metabolic acidosis: Oral alkalinization 
• Hyperphosphatemia: Dietary phosphate restriction,  phosphate binders 
• Hyperparathyroidism: Calcitriol, Vitamin D analogues 
• Hypocalcemia: Calcium supplements  
• Volume overload: Loop diuretics, Ultrafiltration 
• Growth hormone for children with growth failure 
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Indications for renal replacement therapy in patients CKD 
• Severe metabolic acidosis 
• Hyperkalemia 
• Intractable volume overload 
• Pericarditis 
• Encephalopathy 
• Failure to thrive and malnutrition 
• Peripheral neuropathy 
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RENAL REPLACEMENT THERAPY 
 
Renal replacement therapy (RRT) is a broad term encompassing treatment 
modalities that replace the nonendocrine functions of the kidney. RRT is most often 
used in treatment of patients with end stage renal disease. It is occasionally used to 
treat patients with certain forms of poisoning  (69). The following treatment modalities 
are used as RRT: 
 
Intermittent hemodialysis 
Continuous haemodialysis and haemofiltration 
Peritoneal dialysis.  
 
Intermittent haemodialysis is the most commonly used modality and forms the 
backbone of treatment of patients with chronic kidney disease. 
 
 
 
 
 
 
 
 
14 
 
 
RENAL TRANSPLANTATION 
 
Kidney transplantation is a surgical procedure that involves implanting normal 
kidneys from healthy donors to replace diseased ones. Renal transplantation usually 
becomes necessary when patients with chronic kidney disease progress to stage 5 
CKD or ESRD when the kidneys are functioning at less than 15% of their normal 
capacity. Renal replacement therapy may be by either dialysis or by renal transplant.  
 
 
In most health care systems and institutions, dialysis remains the mainstay of 
renal replacement therapy. Recently, significant improvement has been observed with 
graft survival and long term function and this has resulted in renal transplantation 
becoming more cost-effective in comparison with long term dialysis. 
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FACTORS AFFECTING GRAFT FUNCTION 
 
There are a host of recipient factors that influence graft survival and function 
following renal transplantation as listed below (9). 
 
• Age of the recipient 
• Duration of dialysis pre-transplant 
• Anti-HLA antibodies sensitization 
• Delayed graft function 
• Warm ischaemia 
• Cold ischaemia 
• Acute kidney injury (perfusion or reperfusion related) 
• Surgical technique 
• Acute rejection 
• Nephrotoxicity due to Cyclosporine 
 
The improvement in graft survival and function is as a result of these factors 
being understood and addressed by various members of the transplant team. 
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These factors could be broadly classified into two categories; immunological and 
technical. Adequate perfusion of the renal allograft is one of the many technical factors 
that are important in determining early graft survival and function. Adequate perfusion of 
the allograft is directly related to the intra-vascular volume status of the donor first and 
then the recipient and these particular factors to a great extent are under the control of 
the anaesthesiologist. 
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ANAESTHETIC MANAGEMENT 
 
The anaesthesiologist’s role is just one step in the entire process of renal 
transplantation. However, the active role in maintaining adequate intravascular volume 
and intraoperative perfusion pressures would determine immediate graft function and 
delayed graft function (9). 
 
Pre-operative considerations 
 
The main technical factors that are important determinants of graft function are 
warm ischemia time (harvest and transplant time), cold ischemia time (storage time,  
transplanted graft perfusion and pre-donation graft state (9). 
 
Graft perfusion is directly dependant on cardiac output which in turn is dependent 
on the intravascular volume state. When a recipient has been identified they need to be 
fasted and prepared for the transplant operation. This preparation often involves 
dialysis. Dialysis done before the operation can lead to fluid depletion, electrolyte 
disturbance and residual anticoagulation. Though living donor transplantation is a 
scheduled event and therefore allows optimal preparation of the donor and recipient,  
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Intra-operative considerations 
 
 
Renal transplantation is most often performed under general anaesthesia 
although it can also be performed in certain extra-ordinary circumstances under 
neuraxial anaesthesia. General anaesthesia has the advantage of providing a 
haemodynamically stable patient with good muscle relaxation, and predictable depth of 
anaesthesia (10). Sometimes these techniques are combined to provide patients the 
benefits of both. There is no significant difference noted in the hemodynamic and renal 
function among these different techniques (10). Irrespective of the technique employed, 
adequate real time hemodynamic monitoring is essential in patients undergoing renal 
transplantation.  
 
 
In addition to the basic vital parameters that are monitored during any surgical 
operation, monitoring of CVP and arterial blood pressure are considered mandatory 
given the wide variation in haemodynamic state often observed during these major 
operations. In the presence of co-existing heart disease resulting in cardiac dysfunction, 
patients are likely to benefit may also benefit from more advanced monitoring such as 
intraoperative transesophageal echocardiography (11).  
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Patients who have undergone recent dialysis are usually in a state of fluid 
depletion at the beginning of the operation and this is usually reflected as a low CVP. It 
has been shown that administering intravenous fluids to aim for a CVP of 10-15mmHg 
is desirable and results in good graft function (1). This is probably as a result of 
increased renal blood flow. 
 
 
There is often a decrease in CVP observed in towards the end of the operation 
and immediately postoperative in spite of vigorous fluid resuscitation and positive 
balance. The reason for this is not clearly understood. It is believed to be due to two 
possible factors, namely fluid redistribution and change in the vascular tone (70).  
 
 
The importance of fluid balance has been demonstrated beyond doubt in many 
studies. Graft acute tubular necrosis (acute graft injury) has been found to occur less 
often in patients who are vigorously hydrated (12-14). It was demonstrated by Ferris et 
al. that the fluid balance of recipients correlated strongly with immediate post-operative 
graft function (15).  
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In addition to intravenous fluids, pharmacological agents that improve renal blood 
flow such as dopamine and, dobutamine have been used to improve perfusion of the 
transplanted kidney. Diuretics such as Furosemide and Mannitol too have been used to 
improve function of the kidney after reperfusion. The incidence of acute tubular necrosis 
has been observed to be decreased by use of Mannitol (16). It is best to keep the 
patient normotensive or even a little hypertensive so as to assist graft perfusion and 
therefore function. However the use of alpha adrenergic agonists is not recommended 
as they produce vasoconstriction that decreases renal perfusion (16). The goal of the 
anaesthesiologist is to maintain adequate intravascular volume so that the transplanted 
kidney is adequately perfused.  
 
 
Crystalloids are the intra-operative intravenous fluid of choice in renal transplant 
recipients. The fluid of choice is plasmalyte as the other commonly used crystalloids 
have the potential to cause disturbances in electrolyte and acid base balance. There is 
a risk of hyperkalaemia when Ringer’s lactate solution is used. Administration of large 
volumes of normal saline can result in hyperchloraemic metabolic acidosis. This can 
also lead to extracellular potassium shift, and hyperkalemia. Recent evidence suggests 
that plasmalyte more stably maintains acid-base and electrolyte balance compared with 
normal saline especially during the post reperfusion period. (17) 
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Colloids are not routinely used. They are useful in situations where the recipient 
is severely fluid depleted and requires large volume of fluid replacement. (18). Albumin 
is an endogenous colloid that is safe to use in such patients. Though various synthetic 
colloids are more commonly used that albumin in clinical practice, they do not seem to 
offer any significant advantages over albumin (18). The main disadvantage of colloids is 
that there are reports of bleeding complications and renal impairment as a result of 
them (19). Gelatins have a contain high levels of potassium and calcium content and 
are therefore inappropriate for use during renal transplantation (20). The disadvantage 
of Dextran solutions is that they have a tendency to  produce severe hypersensitivity 
reactions and also induce a coagulopathy (21,22). Hydroxyethyl starch (HES) is a 
synthetic colloid with a very good safety profile and therefore preferred to the other 
colloids. It has the lowest in vivo molecular weight and is therefore easily eliminated 
from the system. It is also easily degradable. The most recently done meta-analysis 
showed no adverse renal effects with HES 130/0.4 although the conclusion of the study 
stated that the data was not convincing enough about its safety (23) 
   
 
Of the living related renal transplants, about 90% have immediate urine output. 
Delayed graft diuresis is found to decrease 1-year survival rate from 75% to 49% (24).  
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Patients awaiting renal transplantation usually are on renal replacement 
programmes and undergoing haemodialysis that may result in intravascular volume 
depletion. Haemodialysis done even a few hours prior to surgery may result in weight 
loss of up to 2 Kg or more, indicative of severe dehydration. Among the various intra-
operative measures taken to stimulate urine output, intravascular volume expansion is 
the most important one. Intravascular volume expansion has been associated with 
improved renal blood flow and better immediate graft function (16, 26). Aggressive intra-
operative volume expansion (30ml.Kg-1.h-1) is warranted because a delayed return 
renal graft function causes a 20-40% decrease in transplant graft survival (24,26).  
 
 
Hence an appropriate intraoperative monitor is necessary to access fluid 
responsiveness. Clinical signs such as skin turgor, pulse rate and urine output are easy 
to assess but remain crude and unreliable. Static hemodynamic variables central 
venous pressure (CVP) have remained the standard measuring index. Maintaining a 
CVP between 10 and 15 mm of Hg optimizes cardiac output and renal blood flow 
ensuring good immediate graft function (16,24).   
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ASSESSMENT OF INTRAVASCULAR VOLUME 
 
Hypovolaemia if uncorrected results in end organ hypoperfusion and eventually 
failure which is of special significance to the renal graft. Patients with end stage renal 
disease (ESRD) awaiting renal transplant are usually on haemodialysis and therefore in 
a state of fluid depletion. This state requires to be rapidly corrected during the course of 
the operation so as to achieve a state of normovolaemia by the time circulation to the 
graft is established. This is achieved by intravenous fluid administration.  
 
 
It must also be borne in mind that volume expansion when unregulated can be 
deleterious and therefore is best directed by certain established goals. The concept of 
goal directed volume expansion has been extensively studied in critically ill patients with 
sepsis in intensive care units and therefore, most of the evidence available is in this 
category of patients. These “goals” are essentially to achieve and maintain certain 
haemodynamic parameters that reflect the volume status of the patient within 
established target ranges. Various parameters are used to gauge the adequacy of 
intravascular volume and these are broadly classified as ‘static’ and ‘dynamic’ 
parameters depending on whether or not they are influenced by heart lung interactions.  
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CARDIAC PHYSIOLOGY 
 
The heart is as a muscular pump that is responsible for receiving de-oxygenated 
blood returned from the various organs in the body and pumping oxygenated blood that 
is distributed via the circulatory system to the same organs to enable their vital 
functions. This is achieved by a series of regularly recurring contractions.  
 
 
This pump has two circuits that are interconnected and interdependent. The first 
circuit is the pulmonary circuit (also referred to as the pulmonary circulation) comprising 
the right atrium that receives de-oxygenated blood from the various organs via the 
superior and inferior vena cava and the right ventricle that pumps this de-oxygenated 
blood to the lungs via the pulmonary arteries to the lungs where gas exchange occurs. 
The blood once oxygenated returns to the heart via the pulmonary veins and enters the 
second circuit, the systemic circuit. The systemic circuit (also referred to as the systemic 
circulation) comprises the left atrium that receives oxygenated blood from the lungs via 
the pulmonary veins and the left ventricle that pumps it distributes this oxygenated 
blood to all organs. Usually the left ventricle pumps out approximately 50-60% of the 
blood it receives from the left atrium into the systemic circulation.  
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The body has other regulatory mechanisms that regulate distribution depending 
on the state of body function at the same time maintaining necessary blood flow to vital 
organs such as kidney, liver, brain, intestines and lung. These synchronised functioning 
of these two circuits, that requires rhythmic and synchronised relaxation and contraction 
of the four chambers is controlled by the pacemakers and conduction fibres. The two 
circuits are significantly different in terms of the pressure range in which they function. 
The systemic circulation is a high pressure system, whereas the pulmonary circulation 
is working at low pressure.  
 
 
The volume of blood that is pumped out by the ventricles of the heart with every 
contraction is referred to as the stroke volume (SV). The stroke volumes of right and left 
ventricle are approximately equal. The ventricular end diastolic volume (EDV) is the 
volume of blood in the heart when the ventricles have been filled with blood from the 
atria. The volume of blood being pumped out of the ventricle is dependent on the 
volume of blood that it receives from the atria i.e. the stroke volume is dependent on the 
ventricular end diastolic volume. This is dependent on the total intravascular volume. 
This is referred to as the Frank-Starling principle or the Frank-Starling law. 
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The Cardiac output (CO) refers to the total volume of blood that is pumped out of 
the ventricles every minute (mL blood/min). It is a function of the stroke volume and the 
heart rate and is calculated by the formula:  
 
Cardiac Output = stroke volume (mL) x heart rate (beats/min) 
 
 
The perfusion of various organs in the body is directly dependant on the heart 
providing and adequate output at the adequate pressure. Therefore organ perfusion is 
dependent on the left ventricular end diastolic volume which in a normally functioning 
heart is proportionate to the total intravascular volume. 
 
 
It is easier to measure pressure in the vascular compartments and cardiac 
chambers than the volume and since there is a known relationship between volume and 
pressure in a closed chamber, CVP is accepted as an indicator of Right ventricular end 
diastolic volume and the Left ventricular end diastolic pressure (LVEDP) measured by 
Swan-Ganz catheter, an indicator of left ventricular end diastolic volume (LVEDV). 
Since it is also known that the systemic and pulmonary circulations are in equilibrium, 
the CVP has become over time the most widely used indicator of intravascular volume.  
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However it must be borne in mind that this works on three assumptions; firstly 
that there is a direct linear relationship between pressure and volume, secondly that the 
right and left ventricles are in equilibrium and thirdly that there LVEDV always reflects 
the stroke volume.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LVEDV
• Left ventricular end 
diastolic volume
SV
• Stroke volume
CO
• Cardiac output
• Organ perfusion
• Organ function
Frank Starling curve 
Direct correlation 
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Frank Starling principle (law) 
 
The Frank–Starling law of the heart states that the stroke volume of the heart 
increases with increase in the volume of blood filling the heart (the end diastolic volume) 
when all other factors remain constant.  
 
  
 
Figure 1 – Frank Starling law 
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As preload increases, left ventricular stroke volume increases. This occurs until a 
situation when the stroke volume is optimum. This relationship is due intrinsic ability that 
heart possesses to adapt to increasing volumes of blood inflow. The curve depicted in 
Figure 1 illustrates this relationship. The steep segment of the curve depicts a low 
preload state. In this state, when the preload is increased by increasing intravascular 
volume there will be a corresponding and significant increase in stroke volume. Beyond 
a certain point, continuing to increase the preload does not produce a corresponding 
increase in stroke volume and it tends to remain more or less constant. A patient on the 
steep segment of the curve is considered a “responder” 
 
  
If the preload is known, it will help in predicting the patients responsiveness to 
fluids. However, the shape of the Frank-Starling curve is affected by ventricular function. 
When there is impairment of ventricular function, the curve becomes flattened. That 
implies that there is a much shorter steep segment to the curve. In these situations it is 
not possible to predict the effects of increasing the preload on stroke volume. (27) 
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Heart-lung interactions 
  
The cardiac pump does not function in isolation. It is present within the 
musculoskeletal structure of the thoracic cavity which by itself creates pressure changes 
and gradients during normal inspiration and expiration. These pressure variations which 
are transmitted to the alveoli of the lungs have a bearing on the functioning of the heart, 
particularly when the ventilation is taken over by a mechanical ventilator.  
 
 
Intermittent positive pressure ventilation (IPPV) produces changes in the 
intrathoracic pressure that affect the venous return. This results in the preload and 
afterload of both ventricles to vary cyclically during the phases of ventilation. During 
insufflation of the lung there is a decrease in the right ventricular preload and increase 
in afterload. Increased intrathoracic that occurs when the lungs are insufflated results in 
decreased venous return. This causes the preload to decrease. During inspiration there 
is also an increased transpulmonary pressure. This results in an increased right 
ventricular afterload. The simultaneous decrease in preload and increase in afterload 
lead to a decrease in right ventricular stroke volume. This becomes apparent after two 
to three heart beats (28). 
31 
 
 
 
STATIC PARAMETERS 
 
Central venous pressure 
  
The measurement of central venous pressure (CVP) is very common in clinical 
practice. It is relatively easy to perform at the bedside and can be measured with a 
simple saline manometer or even by simply making a note of jugular venous distension 
on physical examination. However in the intra-operative setting it is usually measured 
continuously using pressure transducers and electronic monitors. The origins of CVP 
monitoring can be traced back to as early as 1959 when it was first described by 
Hughes and Macgovern (29). 
 
 
The CVP has three positive waves and two negative waves that are easily to 
visualize. The positive waves are the ‘a,’ ‘c,’ and ‘v’ waves and the negative waves are 
the ‘x’ and ‘y’ descents. The ‘a’ wave occurs as a result of atrial contraction, the ‘c’ wave 
is produced by the bulging of the tricuspid valves into the right atrium at the onset of 
right ventricular contraction. The ‘x’ descent occurs due to a drop in right atrial pressure 
when the right atrium relaxes. The ‘v’ wave is due to increased atrial pressure as it fills 
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during diastole. The ‘y’ descent is due to the fall in atrial pressure when the 
atrioventricular valve opens and allows the atrium to empty into the ventricle.  
 
 
Among other factors, the ‘y’ descent is affected by the compliance of the heart 
and intra-thoracic pressure (30). During inspiration the “y” descent is more marked and 
this is useful to mark inspiration on the hemodynamic recording of patients who are 
breathing spontaneously.  
 
The best place to measure CVP is the edge of the ‘c’ wave, also called the ‘z’ 
point. This represents the pressure in the atrium and thus the ventricle at the end of 
diastole. 
 
 
 
 
‘a’ wave – atrial contraction 
‘c’ wave – bulging of the tricuspid 
valve at the beginning of systole   
‘x’ descent – atrial relaxation 
‘v’ wave – atrial filling during diastole.  
‘y’ descent – opening of 
atrioventricular valve to allow the 
atrium to empty into the ventricle Figure 2 – CVP trace 
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The CVP has been used for many years to guide fluid management in patients 
undergoing surgery and in the intensive care unit (ICU). A survey conducted in Canada 
on of practices of intensive care physicians revealed that almost 90% of them used the 
CVP as a guide for decisions on fluid management in patients with early septic shock 
(31).  
 
 
Changes in intrathoracic pressures produced by positive pressure ventilation 
especially with positive end-expiratory pressure (PEEP) cause the relationship between 
CVP and right ventricular end-diastolic volume becomes less accurate. Though CVP is 
a marker of right ventricular preload, it is assumed that it reflects the left ventricular 
preload. 
 
 
Marik et al reviewed 24 studies and published a systematic review. They showed 
that the relationship between CVP and intravascular fluid status was actually poor and 
that it was not possible to predict the hemodynamic response to a fluid challenge based 
on the CVP. (32)  
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However, CVP continues to be widely used as a marker of preload and is also 
one of the components of the Surviving Sepsis guidelines. According to these 
guidelines, once lactate is >4 mmol/L or the patient continues to be hypotensive after a 
fluid challenge, the patients should be given fluids so as to maintain a target CVP of ≥8 
mm Hg (12 mm Hg in mechanically ventilated patients). (33) 
 
 
 
Pulmonary artery occlusion pressure 
 
 
The pulmonary artery catheter, also called the Swan-Ganz catheter was invented 
in 1970. It measures the pulmonary artery occlusion pressure (PAOP) which for many 
years was thought to accurately reflect the left ventricular preload. Recent evidence 
however has emerged to suggest that this was not the case and that PAOP was in 
reality a poor reflection of left ventricular preload (34). 
 
 
The Fluid and Catheter Treatment Trial (FACTT) from the Acute Respiratory 
Distress Syndrome (ARDS) Clinical Trials Network compared the outcomes of patients 
with acute lung injury managed using two fluid therapy protocols; one guided by CVP 
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and the other guided by PAOP. The clinical outcomes of these two groups of patients 
were no different (35). 
 
 
The reason for this is that the PAOP value reflects left ventricular end-diastolic 
pressure and not left ventricular end-diastolic volume (preload). The relationship 
between ventricular end-diastolic pressure and end-diastolic volume is not a simple 
linear relationship, but curvilinear and unpredictable (36,37). Therefore PAOP is 
inaccurate in patients who are being mechanically ventilated. The nature of this 
relationship is also the reason why CVP likewise does not accurately reflect the right 
ventricular volume.  
 
 
Though both the CVP and LVEDP have the limitation that pressure volume 
relationship is not linear, they are both accepted commonly and widely as a guide to 
volume management. It must be borne in mind that cardiac diseases and other 
conditions that may make this relationship unpredictable do not exist while managing 
volume based on these pressure measurements(71). 
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Left ventricular end-diastolic area  
 
 
It had become obvious that pressure measurements were not an accurate 
method of estimating the ventricular volume. The next step was to measure the 
dimensions of the ventricle using echocardiography and use these measurements to 
estimate the volume.  
 
 
Left ventricular end diastolic area (LVEDA) is the area mapped in two dimensions 
and measured by transoesophageal echocardiography (TOE/TEE). It has been used by 
both intensivists and anaesthetists and extrapolated to estimate the left ventriculat end 
diastolic volume. It appears that there is a good correlation between LVEDA and 
LVEDV and therefore also with left ventricular preload. Development of single-use 
transoesophageal echocardiography probes that may remain in place for up to 72 hours 
has enabled continuous monitoring of left ventricular volumes and function over time. 
This also allows treating clinicians to assess the patient’s hemodynamic response to 
therapeutic interventions. Though it may be logical to conclude that LVEDA accurately 
assesses LV function, the evidence is equivocal and LVEDA has not been founf to be 
consistently useful (38-41). 
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Inferior vena cava collapsibility 
 
The diameter of the inferior vena cava (IVC) can be measured as it enters the 
right atrium by standard surface or transthoracic echocardiography (TTE). It has been 
demonstrated that the IVC diameter correlates well with central venous pressure and 
right atrial pressure (42). The limitation of the IVC diameter measurement is that it 
essentially reflects the CVP and therefore all the limitations of using CVP as a measure 
of preload are applicable to it as well.  
 
 
More accurate than measuring the diameter of the IVC diameter is to measure 
the collapsibility of the IVC. The IVC collapsibility index is mathematically derived from 
the IVC diameter and is expressed as a percentage. 
 
(IVC dia at end-inspiration – IVC dia at end-expiration) x 100     
  IVC diameter at end-expiration  
 
 
It was demonstrated by Barbier et al that in septic shock, IVC ‘collapsibility’ 
measured by TTE predicted fluid responsiveness accurately (43). 
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However these measurements too are inaccurate in patients who are undergoing 
positive pressure ventilation. Variations in airway pressure tend to have an effect on the 
dimensions of the IVC and hence the IVC collapsibility index.  
 
 
Although this technique seems to provide a quick and non invasive assessment 
of intravascular volume, it is inaccurate in patients undergoing surgery under general 
anaesthesia by positive pressure ventilation (44).  
 
 
Intrathoracic blood volume and global end diastolic volume 
 
 
Intrathoracic blood volume (ITBV) and Global end-diastolic volume (GEDV) are 
both hypothetical volume measurements calculated by the technique of thermodilution.  
 
 
Despite the usefulness of GEDV and ITBV for assessment of hemodynamic 
status, they have not been validated (45-47). 
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It is evident that the main limitation of these static parameters in assessing 
ventricular preload and therefore intravascular volume is that they cease to be accurate 
in patients who are undergoing positive pressure mechanical ventilation as the 
relationship between pressure and volume is altered. Therefore these parameters may 
be unreliable in assessing intravascular volume of patients during the operation. 
 
 
 
DYNAMIC PARAMETERS OF INTRAVASCULAR VOLUME 
 
 
Over the last decade there has been extensive study on heart-lung interactions 
during mechanical ventilation and this knowledge has been used to assess fluid 
responsiveness in patients. These parameters that take into consideration the effect of 
thoracic and pulmonary pressures on the measure intravascular volume are the 
“dynamic” parameters and provide an accurate measure of intravascular volume.  
 
 
 
 
40 
 
Classification of dynamic indices: 
 
 
Dynamic indices can be classified according the methodology used to predict 
preload variation. The first group of indices are those which depend on cyclic variations 
of stroke volume or stroke volume related hemodynamic parameters like pulse pressure 
or aortic blood flow determined by mechanical ventilation induced variations in 
intrathoracic pressure. The second group of indices are those based on cyclic variation 
of non stroke volume related hemodynamic parameters like vena cava diameter 
determined by mechanical ventilation. The third group are those based on preload 
redistribution manoeuvres like passive leg raising.  
 
 
Pulse pressure variation and Stroke volume variation 
 
 
The pulse pressure (difference between systolic and diastolic pressure) is directly 
proportional to left ventricular stroke volume and inversely related to arterial compliance. 
The Pulse pressure variation (PPV) is the variation in this difference during the course 
of the repiratory cycle. Stroke volume variation is the variation that occurs in stroke 
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volume during the respiratory cycle. Both PPV and SVV can be measured continuously 
by most standard cardiac monitors.  
 
 
Pulse Pressure Variation and Stroke Volume Variation predict an individual 
patient’s position on the Starling curve. This is independent of ventricular function and 
compliance as well as pulmonary pressures and mechanics.  
 
 
Marik et al showed that PPV and SVV accurately predicted those patients who 
were likely to be responders to fluid challenge, even during volume-controlled 
mechanical ventilation (48).  Lopes et al also  demonstrated  in another study that when 
fluid management was based on the PPV, the frequency of postoperative complications, 
duration of mechanical ventilation, ICU and hospital length of stay were all significantly 
reduced (49).  
 
 
There are however certain situations such as cardiac arrhythmias and 
spontaneous breathing when PPV and SVV may not accurately reflect intravascular 
volume. Both these measurements are influenced by tidal volume and airway pressure. 
Therefore if tidal volume and airway pressure are controlled, PPV and SVV will 
accurately reflect intravascular volume. The effect of tidal volume on the ability of SVV 
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and PPV to predict intravascular volume has been studied and demonstrated. Reuter et 
al. demonstrated the effect of depth of tidal volume on SVV (51) and De Baker et al 
demonstrated that the tidal volume was to be set at least at 8 mL/kg for the PPV 
readings to be accurate (52).  
 
 
 
Pulse oximeter plethysmographic waveform 
 
 
Variations in the plethysmographic waveform amplitude during respiration have 
been correlated with respiratory variations in PPV and can predict fluid responsiveness 
in patients undergoing surgery (53). The pulsatile infrared signal is indexed against the 
nonpulsatile signal to derive the perfusion. This corresponds with the amplitude of the 
pulsoximeter wave.  
 
 
The ‘pleth variability index’ (PVI) is an automated measure of the dynamic 
change in the perfusion index (PI) that occurs during a respiratory cycle. Zimmerman et 
al showed that PVI was as accurate as SVV in predicting fluid responsiveness (53). 
Though this technique seems an excellent and at the same time simple and non-
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invasive method of monitoring of fluid responsiveness it may be erroneous in patients 
who are on inotropes as they will not have good waves on pulse oximetry. 
 
 
Dynamic changes in aortic flow velocity  
 
 
Transoesophageal echocardiography is used to measure changes in aortic blood 
flow velocity at the aortic annulus. Aortic blood flow volume changes should reflect 
changes in LV stroke volume assuming that the diameter of the aorta is constant. 
 
 
Superior vena cava collapsibility index 
 
Fluid responsiveness is predicted by the changes in superior vena cava (SVC) 
diameter that occur in a cyclical manner. It is measured using transoesophageal 
echocardiography. 
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Off all the dynamic parameters described above, the one that is simplest to 
measure and therefore the focus of further discussion is the PPV. The most commonly 
used static parameter is CVP and is often used as the standard against which PPV and 
other newer parameters are compared. 
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PULSE PRESSURE VARIATION 
 
 
The pulse pressure is defined as the difference between the systolic and the 
diastolic pressure. It is directly proportional to LV stroke volume. The pulse pressure is 
not directly influenced by the variations in intrathoracic pressure produced by 
mechanical ventilation. This is because mechanical ventilation affects both diastolic and 
systolic pressures and this effect gets cancelled out as this is a mathematical difference. 
Changes in peripheral pulse pressure during the respiratory cycle therefore reflect the 
LV stroke volume (54). There has been a lot of interst recently in studying the use of 
pulse pressure (PPV) to assess fluid responsiveness and fluid status. 
 
 
It was possible to discriminate between responders (defined as patients who 
experienced an increase in cardiac index of 15% in response to volume expansion)  and 
non responders using PPV. A cut off value of 13% had sensitivity and a specificity of 94 
and 96%, respectively.  
 
 
PPV was a more reliable indicator of fluid responsiveness than the respiratory 
changes in systolic pressure (55). The increase in cardiac index as a result of volume 
expansion correlated well with a decrease in PPV, such that changes in PPV could be 
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used to assess the hemodynamic changes that occurred as a result volume expansion. 
Various studies have been done using these dynamic indices as markers of volume in 
patients (55).  
 
 
 
 
 Figure 3 – Impact of mechanical ventilation on the stroke volume 
Michard et al. Critical Care 2007 (11):13  
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Until recently, it was not possible to obtain a realtime PPV value as it had to be 
calculated offline. Of late most standard bed side monitors have software built in to 
automatically calculate and display the PPV as a continuous realtime reading. This has 
made it extremely simple to measure this parameter without any additional procedures 
or the use of special monitoring devices. 
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ADVANTAGES OF PPV OVER CVP  
 
 
Of all the parameters listed above the simplest to estimate are the central venous 
pressure (CVP) and the pulse pressure variation (PPV) 
 
 
Central venous pressure is considered equivalent to right atrial pressure, which, 
in the absence of tricuspid valve disease, is equal to right ventricular end diastolic 
pressure. Central venous pressure in addition to tricuspid valve abnormality is 
influenced by intravascular volume and right ventricular function. It therefore can be 
considered to be an accurate indicator of right ventricular preload in the absence of any 
right heart disease.  
 
 
It however must be remembered that measuring the CVP alone cannot provide 
an assessment of volume status and assessment of the preload of the heart. This is 
because CVP and cardiac output are determined by the interaction of two function 
curves: the cardiac function curve and the venous return curves (56). Therefore to 
interpret CVP one has to have a fairly good idea of the cardiac output. This does not 
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have to be an actual measurement of cardiac output and could even be a clinical 
assessment (57). 
 
 
 
 
 
 
Figure 4 – interaction of cardiac function and venous return curves 
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Dynamic measures such as the systolic pressure variation (SPV), pulse pressure 
variation (PPV) and the stroke volume variation (SVV) are derived from the analysis of 
the arterial pressure waveform.  
 
 
Dynamic variables based on the respiratory induced arterial pressure variations 
(RIAPV) appear as cyclical peaks and troughs on the arterial pressure waveform. 
Intermittent positive-pressure ventilation results in the occurrence of cyclic changes in 
the preload and after load of both the ventricles. Mechanical insufflation decreases right 
ventricular preload and increases its afterload. The reduced RV preload and increased 
RV afterload leads to a decrease in RV stroke volume. This reduction in RV ejection 
during inspiration leads to a decreased return to the left atrium and therefore a reduction 
in left ventricle (LV) filling after a phase lag of two or three heartbeats because of the 
time it takes for blood to go through the pulmonary circulation. This is referred to as the 
pulmonary transit time. The resulting LV preload reduction causes a subsequent 
decreased LV stroke volume. There is therefore a cyclic variation that occurs in the 
stroke volumes of both the left and right ventricles as a result of positive pressure 
ventilation. These changes are more pronounced when the ventricles operate on the 
steep rather than the flat portion of the Frank-Starling curve. Therefore, the magnitude 
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of the respiratory change in LV stroke volume is an indicator of biventricular preload 
dependence predictive factors of volume expansion efficacy to select patients who 
could benefit from volume expansion and avoid ineffective fluid therapy in 
“nonresponders” in whom inotropic and/or vasopressor support should preferentially be 
used (48) 
 
 
PPV is derived from the arterial catheter placed to measure ABP by means of 
commonly available transducers and modules. The airway pressure too is monitored to 
estimate the commencement and completion of the respiratory cycle. Pulse pressure 
(PP) is calculated as the difference between systolic and diastolic arterial pressure. 
Maximal PP (PPmax) and minimal PP (PPmin) are calculated over a single respiratory 
cycle, which is determined from the airway pressure signal. PPVs are calculated in 
terms of PPmax and PPmin and expressed as a percentage.   
 
The PPV is calculated using the following formula:- 
 
PPV =      (PP max – PP min)     X 100 
½ x (PP max + PP min) 
 
 
Recently monitoring software has been developed that enables the automated 
estimation and display of PPV (58). 
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Though commonly used, the standard preload indices such as Central Venous 
Pressure (CVP) have been shown to be inferior to Pulse Pressure Variation (PPV) and 
Stroke Volume Variation (SVV) in predicting cardiac function (58-60). Measurement of 
PPV has the advantage of being able to predict an increase in cardiac output induced 
by volume expansion even before fluids are administered (61). PPV being a dynamic 
parameter is in theory, a more accurate reflection of the intravascular fluid volume than 
CVP which is a static parameter (48, 61-63).  In spite of this recent knowledge CVP 
enjoys more favour as a measure of intra-vascular volume mainly because PPV has not 
been studied in many situations, one of them being in patients undergoing renal 
transplantation.  
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THE EVIDENCE IN FAVOUR OF PPV AND SVV 
 
Auler et al studied if fluid responsiveness could be predicted by PPV in patients 
who were being mechanically ventilated. This was a prospective observational study. 59 
patients who were mechanically ventilated in the postoperative period following cardiac 
surgery were studied. None of the patients were at high risk for fluid overload as a result 
of fluid administration (pulmonary artery occlusion pressure < 20 mm Hg, left ventricular 
ejection fraction > or = 40%). A peripheral arterial cannula and a pulmonary artery 
catheter were inserted in all patients. Cardiac filling pressures and cardiac output were 
measured before and after intravascular fluid administration and pulse pressure 
variation was automatically calculated and continuously monitored. In 39 of the 59 
patients (approximately 66%) there was an increase cardiac output by at least 15% with 
administration of intravenous fluids. These patients were considered responders and 
the others, non responders. Both responders and nonresponders had comparable right 
atrial and pulmonary artery occlusion pressures prior to fluid administration. However, 
there was a significantly greater variation in pulse pressure in responders than in 
nonresponders. A cut-off value of 12% allowed identification of responders with a 
sensitivity of 97% and a specificity of 95%. They concluded that pulse pressure variation 
was a reliable method to predict fluid responsiveness after cardiac surgery (64) 
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Kramer et al studied ability of PPV to predict fluid responsiveness in patients who 
had undergone coronary artery bypass grafting. The study was done to determine 
whether fluid responsiveness as evidenced by an increase in cardiac output could be 
predicted by the degree of pulse pressure variation (PPV) and 
systolic pressure variation (SPV) in postoperative patients following CABG, and to 
determine whether PPV was superior to SPV in this setting. Twenty-one patients who 
had undergone CABG were studied immediately after arrival in the ICU following the 
operation.  Hemodynamic parameters such as central venous pressure (CVP), 
pulmonary artery occlusion pressure (PAOP), Cardiac output, SPV and PPV were 
measured when the patient was brought into the ICU. All the patients received a rapid 
infusion fo 500mL of intravenous fluid after which all the parameters were measured 
again. They were classified into two groups based on whether or not the carciac output 
had increased by ≥ 12%. Those whose cardiac output increased were considered to 
be fluid responders and the others, non responders. The ability of the various 
haemodynamic parameters to distinguish between responders and nonresponders was 
compared.  
 
In response to the fluid infusion, 6 patients were responders and 15 were 
nonresponders. It was found that there was no difference in the change in CVP and 
PAOP between these two groups. However, the SPV and the PPV were significantly 
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higher in responders than in nonresponders. ROC curve analysis suggested that the 
PPV was the best predictor of fluid responsiveness. The ideal PPV threshold for 
distinguishing responders from nonresponders was found to be 11. A PPV value of 
>11% predicted an increase in CO with 100% sensitivity and 93% specificity. It was also 
shown that PPV was superior to SPV at predicting fluid responsiveness. Both of these 
measures were far superior to both CVP and PAOP (65)  
 
Benes et al studied the use of stroke volume variation in patients coming for high 
risk major abdominal surgery. The study aimed at evaluating whether fluid management 
and optimization based on stroke volume variation (SVV) made a difference to the 
postoperative vital organ function and morbidity. This study was done on high risk 
patients undergoing major abdominal surgery. Fluid fluid optimization guided by SVV 
was found to be associated with better a significantly lower incidence of postoperative 
complication (66). 
 
Lopes et al studied goal-directed fluid management based on achieving a target 
value of pulse pressure variation during high-risk surgery. This was a prospective, 
randomized, single-centre study. The primary end point was the length of postoperative 
stay in hospital. Pulse pressure variation was monitored during the surgery and fluid 
management was carried out keeping the PPV targeted to less than 10%. They found 
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that the group that received IV fluids based on PPV had less complications in the post 
operative period and had shorter post operative stay in hospital (67). 
 
Mayer et al performed a randomised controlled trial to aimed to study the 
advantage of goal-directed intraoperative fluid therapy that was based on cardiac index 
over intra-operative fluid therapy based on standard protocol in patients undergoing 
abdominal surgery and to evaluate possible improvements in patient outcome as 
determined by the duration of hospital stay and the incidence of complications 
compared to a standard fluid management protocol. Cardiac index was estimated using 
a minimally invasive, easy to use, commercially available device (FloTrac/Vigileo), 60 
high-risk patients scheduled for major abdominal surgery were included and 
randomised into one of two arms of 30 each. Patients in the study arm were monitored 
using a FloTrac/Vigileo device and had fluid management using a cardiac index based 
intraoperative optimization protocol. Patients in the control group were managed using 
traditional monitoting and a fluid management protocol. It was found that patients in the 
study group in whom intraoperative goal-directed hemodynamic optimization protocol 
using the FloTrac/Vigileo device was carried out, had a shorter duration of hospital 
admission and fewer complications compared to those in the control arm (68) 
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This study aims to assess how accurately PPV reflects adequacy of intra-
vascular volume in patients who are undergoing renal transplantation by checking its 
correlation with time to graft diuresis onset.  
 
We have assumed that time to graft dieresis is a good indicator of the 
intravascular volume status, 
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MATERIALS AND METHODS 
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STUDY DESIGN:  
Observational study – Cohort design 
 
 
INCLUSION CRITERIA:  
All patients with ESRD undergoing renal transplantation 
 
 
DURATION OF STUDY: 
January 2014 to August 2014 
 
 
EXCLUSION CRITERIA:  
Age < 18 yrs.  
Ejection fraction < 40% 
Cardiomyopathy 
Arrhythmias 
Emergency transplants. 
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PROCEDURE 
• Clearance was obtained from the institutional review board to perform the study 
in its present format. 
• All adult patients undergoing elective renal transplantation who did not have 
significant cardiac dysfunction were included after obtaining written consent.  
• In all patients peripheral venous access was first established and basic 
monitoring (ECG and Pulse-oximeter) was  commenced. End tidal CO2 
monitoring was commenced after induction.  
• Anaesthesia was induced with Fentanyl 2mcg/Kg, Propofol 2mg/Kg and 
Rocuronium 0.1mg/Kg.   
• Patients were intubated using an appropriate sized endotracheal tube and 
intermittent positive pressure ventilation established using a mechanical 
ventilator (Datex Ohmeda Aestiva / Aespire) with volume control ventilation and 
tidal volume set at 8ml/Kg.  
• All patients had a triple lumen 8F catheter inserted into the internal jugular under 
aseptic precautions to measure CVP and a 20G cannula into the radial artery to 
monitor arterial blood pressure (ABP) as was standard practice.  
• All hemodynamic parameters including the CVP and ABP were measured 
continuously throughout the procedure using pressure .  
• PPV is mathematically derived from the ABP using the following formula:   
PPV =      (PP max – PP min)     X 100 
½ x (PP max + PP min) 
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• This calculation was performed automatically by the anaesthetic monitor (Philips 
Intelli Vue MP50) and displayed as a continuous real-time value.   
• All variables as mentioned in the proforma (attached) were recorded every 15 
minutes.  
• Intra-operative fluid management was planned to target a CVP of 15mm of Hg.  
• It was planned that hypotension would be treated by either fluid boluses or 
vasopressors such as ephedrine depending on the CVP.  
• The PPV value was recorded but not used to make decisions in fluid 
management.  
• The time to urine output (in seconds) following revascularization of the renal graft 
(release of vascular clamps) was recorded and this was used as an indirect 
indicator of adequacy of intravascular volume. 
• The total estimated blood loss was noted down at the end of surgery. 
•  Reversal of neuromuscular blockade was done with neostigmine and 
glycopyrolate.  
• Patients were extubated when fully awake.  
• Post operatively patients were shifted to the recovery area within the operating 
theatre complex where they continued to be monitored.  
• Urine output in the first 4 hours was measured and recorded. 
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OUTCOMES 
 
Primary - Time to urine output (sec)  
Secondary - Urine output (mL)  
 
As all hemodynamic measurements were recorded directly from a monitor there was no 
room for bias or subjective error. 
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Figure 5 – Screen shot from Philips Intelli-Vue MP50 monitor 
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SAMPLE SIZE CALCULATION   
Regression methods - Sample size for correlation coefficient analysis  
(testing against population value) 
Sample correlation coefficient  -0.8 -0.7 0.8 
Population correlation coefficient  -0.4 -0.4 0.5 
Power (1- beta) % 80 80 80 
Alpha error (%) 5 5 5 
1 or 2 Sided 2 2 2 
Required sample size 20 43 29 
 
 
In order to get a correlation of -0.8 (correlation between PPV and time to urine 
production), and show that it is significantly different from null hypothesis correlation of -
0.5, instead of 0, keeping alpha and beta errors at 5% and 20% respectively we need to 
study 29 subjects. However this size is 43, when we test the correlation of -0.7 with -0.4 
with the same errors levels. Therefore, we planned to study 40 subjects.  
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STATISTICAL ANALYSIS 
 
The PPV and time to urine were considered as continuous variables to study the 
correlation between the two variables and construct the scatter plot. However, for the 
ROC analysis to the time to urine was categorized as <120 seconds and ≥ 120 
seconds. 
 
Data was entered in EPIDATA software and was cleaned using Box-Cox plots, 
histogram and scatter plots. The histograms were used as a guide to identify the 
distribution such as normal or non-normal etc. It was planned to derive the Person 
Correlation coefficient if the distribution is nearly normal and to use a nonparametric 
method if the distribution was not normal. Time to urine was categorized as <120 sec 
and >= 120 sec for the purpose of the ROC curve analysis and the best cut off was 
identified. After finding the best cut off value validity and predictive values such as 
Sensitivity, Specificity, Positive and Negative Predictive values will be estimated and 
presented with 95% CI.    
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RESULTS 
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STUDY FLOW CHART 
 
 
 
 
 
 
 
 
 
 
 
 
All patients undergoing  
elective renal transplantation 
37 
Measurement of CVP  
Measurement of Arterial 
BP, PPV 
      
Assessment of correlation of PPV 
with time to urine output  
Exclusion Criteria 
Consent denied - 2 
Age < 18 yrs - 1 
EF < 40% - 1 
Cardiomyopathy - 0 
Arrhythmias - 0 
Cohort of patients included in 
the study 
33 
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CONSOLIDATED DATA OF ALL SUBJECTS RECRUITED 
Sino. Age Sex TOD CVP start CVP CCR CVP UO 
PPV 
start 
PPV 
CCR PPV UO TUO 
UO 
4hrs 
1 35 M CAPD 10 11 11 13 4 5 384 3040 
2 29 F 22 11 28 27 6 9 5 84 1200 
3 21 M 18 14 12 11 9 11 8 80 1950 
4 41 M 18 10 12 16 8 6 6 82 2100 
5 27 M 18 11 15 17 7 4 5 55 2400 
6 33 M 18 7 10 11 9 11 3 118 1800 
7 22 M 17 7 9 9 14 9 10 108 1850 
8 20 M 15 8 16 14 5 7 6 35 2200 
9 36 M 18 2 4 4 10 12 7 226 1100 
10 57 M 23 7 13 14 11 5 4 120 2400 
11 35 F ND 8 10 14 7 8 7 66 3600 
12 24 F ND 3 6 14 6 5 3 4 2500 
13 24 F 7 4 9 9 7 4 4 92 1500 
14 28 M 18 11 15 15 4 4 6 150 2000 
15 32 M 16.5 11 18 21 7 3 3 92 1800 
16 32 M 18.5 14 15 16 7 16 10 71 2000 
17 28 F 18 12 14 15 6 8 8 3 2400 
18 20 M 19 3 12 12 7 5 5 30 2500 
19 40 F 16 11 15 15 14 14 6 128 1800 
20 31 F 15.5 13 15 17 6 7 5 62 2000 
21 45 M 21 18 14 16 2 10 4 485 500 
22 19 M 21 9 16 15 4 12 12 166 100 
23 33 M 19.5 7 12 15 4 8 10 75 1550 
24 50 F 18 10 20 18 10 4 8 120 1500 
25 48 F 15 7 10 11 6 8 4 120 500 
26 45 M 17 2 10 8 14 3 7 62 700 
27 23 M 22 10 8 7 7 7 7 45 2100 
28 19 F 18 8 15 12 6 3 7 660 2000 
29 43 M ND 12 12 11 12 21 20 10 1500 
30 24 F 46 7 14 7 13 4 6 203 2400 
31 57 M 17 13 16 17 7 3 3 88 3200 
32 21 M 21 0 14 20 13 6 4 70 3800 
33 20 M 20 11 15 17 16 14 20 300 2500 
Mean 32.18   19 8.818182 13.18182 13.8182 8.39394 7.72727 6.90909     
 
TOD – Time from last haemodialysis   CVP start – CVP at start of operation 
CVP CCR – CVP at cross clamp release   CVP UO – CVP when urine output started  
PPV start – PPV at start of operation   PPV CCR – CVP at cross clamp release 
PPV UO – PPV when urine output started  TUO – Time to Urine Output 
UO 4 hrs – Urine output in first 4 hours 
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DEMOGRAPHICS 
 
Of the 37 elective renal transplants that happened during the study period, 33 
patients were included in the study. Two patients did not consent to participate, one was 
less than 18 years of age and one had severe cardiac disease with an ejection fraction 
of 40% 
 
There were 22 males and 11 females and the mean age of the study group was 
32.2 years.  
 
67%
33%
Figure 6 - Sex distribution
Male Female
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Most patients (22 of 33) were hypertensive. This was probably a 
consequence of the renal failure rather than its cause. 
 
Of the 33, 29 were on maintenance haemodialysis and one was on 
continuous ambulatory peritoneal dialysis. Three were not on any form of 
renal replacement prior to transplant. The average duration between last 
haemodialysis and transplant for the 29 patients that were on 
haemodialysis was 19 hours. 
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CVP MEASUREMENT 
 
At the start of the operation only 16 of the 33 patients had CVP that was within 
the desired range of 10-15 mm of Hg. 17 of the 33 patients had a CVP below the 
desired range of 10-15 mm Hg.  
 
At the time of cross clamp release, 22 of the 33 patients had a CVP within the 
desired range of 10-15 mm Hg and 6 patients had CVP over 15 mm Hg. Only 5 patients 
had CVP still less than 10 mm Hg.  
 
 Start of operation Reperfusion of graft 
 
CVP < 10 mm of Hg 
 
17 5 
 
CVP 10 -15 mm of Hg 
 
16 22 
 
CVP > 15 mm of Hg 
 
0 6 
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This shows that a significant number of the patients were in a fluid depleted at 
the start of the operation, but with intra-operative fluid management this state was 
corrected in most of them.   
 
PRIMARY OUTCOME MEASURE – TIME TO URINE OUTPUT 
  
When grouped according to time to urine output it was observed that most 24 of 
the 33 patients (72.7%) had a urine output within 120 seconds of revascularization of 
the graft as illustrated in figure 5.  
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Figure 7 – Distribution of patients according to time to urine output 
73 
 
DESCRIPTIVE STATISTICS OF PULSE PRESSURE 
VARIATION AT CROSS CLAMP RELEASE (PPV-CCR) AND 
TIME TO URINE OUTPUT (TUO): 
 
All baseline variables were summarized using descriptive statistical methods 
(Mean, Standard deviation, Frequencies and Percentages). 
  
The mean and the median values of the PPV and the two outcome variables, 
Time to urine output (TUO) and Urine output in the first 4 hours (4 hr UO) are as 
follows:-  
 
Variables Mean(SD) Median (IQR) Min max 
 
CVP (in mm Hg) 
 
13.18 (4.29) 14.00 (5.00) 4 28 
 
PPV CCR (%) 
 
7.73 (4.30) 7.00 (6.00) 3 21 
 
TUO (in sec) 
 
133.15 (140.37) 88.00 (77.00) 3 660 
 
4 hr UO (in ml) 
 
1954.24 (830.10) 2000.00 (900.00) 100 3800 
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It is evident from the above table that both Pulse Pressure Variation 
measurements at the time of cross clamp release (PPV-CCR) and Time to Urine Output 
(TUO) were not normally distributed. This was confirmed by the Shapiro Wilk test that is 
a statistical test for normality (p value=0.003 for PPV CCR & p value=0.000 for TUO). 
The time to urine output varied from as low as 3 seconds to as 660 seconds. 
  
 
This is also evident from the histograms and Box Cox plots of these two 
variables. These plots indicate that both the variables were not normally distributed and 
with presence of outliers. 
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Figure 8 – Histogram of Pulse pressure variation at cross clamp 
release (PPV CCR): 
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Figure 9 – Box Cox Plot of PPV CCR: 
 
There was one patient with a PPV of 21% at the time of cross clamp release and 
this was clearly an outlier. This patient had a CVP of 11 mm of Hg at the time of cross 
clamp release, which was within the normal range of 10-155 mm of Hg, and the time to 
urine output was 10 seconds, which too was well within the desired time limit.  
 
77 
 
Figure 10 – Histogram of Time to Urine Output (TUO) (in sec) 
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Figure 11 – Box Cox Plot of Time to Urine Output (TUO): 
 
Though this distribution was closer to normal than the distribution of PPV, there 
were four outliers with very delayed urine outputs. 
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CORRELATION BETWEEN CENTRAL VENOUS PRESSURE 
AND TIME TO URINE OUTPUT 
There was no obvious linear correlation between the CVP and TUO when plotted 
together as illustrated in figure 10. The CVP measurements are arranged in ascending 
order and there is no corresponding inverse linear pattern as would be expected. 
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Figure 12 – Distribution of TUO measurements after arranging CVP in order 
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CORRELATION BETWEEN PULSE PRESSURE VARIATION 
(PPV) AND TIME TO URINE OUTPUT 
PPV was measured automatically by the monitor but these values did not 
influence decisions on fluid management. There was no obvious linear correlation 
between the PPV and TUO when plotted together as illustrated in figure 11. The PPV 
measurements are arranged in ascending order and there is no corresponding linear 
pattern. 
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Figure 13 – Distribution of TUO measurements after arranging PPV in order 
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Scatter Plot of Pulse pressure variation at cross clamp release (PPV-
CCR) and time to urine output (TUO) 
 
 
 
 
 
 
 
 
 
Figure 14 – Scatter plot of PPV-CCR and TUO 
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Correlation between PPV CCR and TUO (Non parametric Spearman) 
Correlations 
   PPV CCR 
(%) 
TUO 
(sec) 
Spearman's 
rho 
PPV CCR 
(%) 
Correlation 
Coefficient 
1.000 .002 
Sig. (2-tailed) . .990 
N 33 33 
TUO (sec) Correlation 
Coefficient 
.002 1.000 
Sig. (2-tailed) .990 . 
N 33 33 
 
 
There was no correlation between pulse pressure variation at cross clamp 
release (PPV CCR) and Time to Urine Output (TUO). 
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Based on the scatter plot, the outliers were removed (considered only 
TUO less than or equal to 250) i.e., 4 observations were removed. 
 
Scatter Plot of PPV CCR and TUO after deleting the outliers: 
 
 
  
 
 
 
Figure 15 – Scatter plot of PPV-CCR and TUO after deleting outliers 
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Correlation between PPV CCR and TUO (Non parametric Spearman) 
after removing the outliers: 
 
Correlations 
   PPV CCR 
(%) 
TUO 
(sec) 
Spearman's 
rho 
PPV CCR 
(%) 
Correlation 
Coefficient 
1.000 .038 
Sig. (2-tailed) . .843 
N 29 29 
TUO (sec) Correlation 
Coefficient 
.038 1.000 
Sig. (2-tailed) .843 . 
N 29 29 
 
 
There was no correlation between pulse pressure variation at cross clamp 
release (PPV CCR) and Time to Urine Output (TUO) even after removing the outliers. 
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ROC analysis using 60 seconds as the cut off value for time to urine 
output 
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>=4
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Area under the ROC Curve: 
 
Area 
 
 
0.5000 
 
Std. Error 
 
 
0.1134 
 
95% confidence interval 
 
 
0.2777 to 0.7223 
 
P value 
 
 
1.000 
 
 
From the graph of ROC curve, the best cut off may be taken as “≥8” which gives 
the Sensitivity of 50% and Specificity of 71.43%.  The Likelihood Ratio suggests the 
same best cut off value. 
 
The sensitivity of 50% and specificity of 71.43% indicate that this PPV is highly 
specific but not very sensitive.    
 
 
 
 
87 
 
ROC analysis using 120 seconds as the cut off for time to urine 
output 
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Area under the ROC Curve: 
 
Area 
 
0.5694 
 
Standard Error 
 
0.1334 
 
95% confidence interval 
 
0.3079 to 0.8310 
 
P value 
 
0.5443 
 
 
From the graph of ROC curve, the best cut off was taken as “≥10” which gives 
the Sensitivity of 55.56% and Specificity of 83.33%.  The Likelihood Ratio suggests the 
same best cut off value. 
 
The sensitivity of 55.56% and specificity of 83.33% indicate that PPV is highly 
specific but not very sensitive.    
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It was considered more appropriate to use 120 as the cut off as most patients 
would fall within the desired range and therefore the results would be clinically more 
relevant.  
 
The sensitivities and specificities from the ROC curve are in the tables that 
follow.  
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Cutoff Sensitivity% 95% CI Specificity% 95% CI 
Likelihood 
ratio PPV% 
95% 
CI of 
PPV 
 
NPV% 
95% 
CI of 
NPV 
 
>= 4 88.89 51.75% to 99.72% 12.5 2.656% to 32.36% 1.016 27.59 11.32 43.85 75.00 32.57 100.00 
>= 5 55.56 21.20% to 86.30% 25 9.773% to 46.71% 0.7407 21.74 4.88 38.60 60.00 29.64 90.36 
>= 6 55.56 21.20% to 86.30% 37.5 18.80% to 59.41% 0.8889 25.00 6.02 43.98 69.23 44.14 94.32 
>= 7 55.56 21.20% to 86.30% 45.83 25.55% to 67.18% 1.026 27.78 7.09 48.47 73.33 50.95 95.71 
>= 8 55.56 21.20% to 86.30% 58.33 36.64% to 77.89% 1.333 33.33 9.48 57.19 77.78 58.57 96.98 
>= 9 55.56 21.20% to 86.30% 75 53.29% to 90.23% 2.222 45.45 16.03 74.88 81.82 65.70 97.94 
>= 10 55.56 21.20% to 86.30% 83.33 62.62% to 95.26% 3.333 55.56 23.09 88.02 83.33 68.42 98.24 
>= 11 44.44 13.70% to 78.80% 83.33 62.62% to 95.26% 2.667 50.00 15.35 84.65 80.00 64.32 95.68 
>= 12 44.44 13.70% to 78.80% 91.67 73.00% to 98.97% 5.333 66.67 28.95 100.00 81.48 66.83 96.13 
>= 13 22.22 2.815% to 60.01% 91.67 73.00% to 98.97% 2.667 50.00 1.00 99.00 75.86 60.29 91.44 
>= 15 0 0.0% to 33.63% 91.67 73.00% to 98.97% 0 0.00 0.00 0.00 70.97 54.99 86.95 
>= 18 0 0.0% to 33.63% 95.83 78.88% to 99.89% 0 0.00 0.00 0.00 71.88 56.30 87.45 
 
 
 
 
 
 
 
SENSITIVITY AND SPECIFICITY VALUES USING DIFFERENT CUTOFFS OF PPV (TAKING 120 SECONDS TO BE DESIRED TIME TO 
URINE OUTPUT) 
The best cut off value was ≥10%. Therefore the targeted PPV should be <10% to predict post transplant diuresis in under 120 
seconds 
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Cutoff Sensitivity% 
95% CI of 
Sensitivity Specificity% 
95% CI of 
Specificity 
Likelihood 
ratio PPV% 95% CI of PPV NPV% 
95% CI of 
NPV 
>=4 84.62 65.13% to 95.64% 0 0.0% to 40.96% 0.85 75.86 60.29 91.44 0.00 0.00 0.00 
>=5 65.38 44.33% to 82.79% 14.29 0.3610% to 57.87% 0.76 73.91 55.97 91.86 10.00 0.00 28.59 
>=6 61.54 40.57% to 79.77% 42.86 9.899% to 81.59% 1.08 80.00 62.47 97.53 23.08 0.17 45.98 
>=7 53.85 33.37% to 73.41% 42.86 9.899% to 81.59% 0.94 77.78 58.57 96.98 20.00 0.00 40.24 
>=8 50 29.93% to 70.07% 71.43 29.04% to 96.33% 1.75 86.67 69.46 100.00 27.78 7.09 48.47 
>=9 38.46 20.23% to 59.43% 85.71 42.13% to 99.64% 2.69 90.91 73.92 100.00 27.27 8.66 45.88 
>=10 30.77 14.33% to 51.79% 85.71 42.13% to 99.64% 2.15 88.89 68.36 100.00 25.00 7.68 42.32 
>=11 26.92 11.57% to 47.79% 85.71 42.13% to 99.64% 1.89 87.50 64.58 100.00 24.00 7.26 40.74 
>=13 11.54 2.446% to 30.15% 85.71 42.13% to 99.64% 0.81 75.00 32.57 100.00 20.69 5.95 35.43 
>=15 3.846 0.09733% to 19.64% 85.71 42.13% to 99.64% 0.27 50.00 0.00 100.00 19.35 5.45 33.26 
>=18 0 0.0% to 13.23% 85.71 42.13% to 99.64% 0.00 0.00 0.00 0.00 18.75 5.23 32.27 
SENSITIVITY AND SPECIFICITY VALUES USING DIFFERENT CUTOFFS OF PPV (TAKING 60 SECONDS TO BE DESIRED TIME TO URINE 
OUTPUT) 
The best cut off value was ≥8%. Therefore the targeted PPV should be <8% to predict post transplant diuresis in under 60 seconds. 
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DISCUSSION 
 
 
 
 
 
 
 
93 
 
 
Outcome following renal transplantation is dependent on many factors some of 
these are immunological and therefore not under the control of the surgical procedure. 
Also donor kidney related factors have a role to play in graft function and outcomes. 
There are technical or mechanical factors often directly related to the actual surgical 
procedure which have over the years been standardized. Of the technical factors, the 
one factor that is directly under the control of the anaesthesiologist is the intravascular 
volume status of the recipient. This in turn has a bearing on the cardiac output and 
therefore perfusion of the graft. The intravascular volume status is controlled effectively 
by fluid management. 
 
Fluid management in renal transplant can be specially challenging to the 
anaesthesiologist as most patients are in a state of fluid depletion as a result of 
haemodialysis while waiting for a transplant. There is a need to rapidly correct this 
intravascular depletion before the time of perfusion of the renal graft that occurs with 
vascular cross clamps on the vascular pedicle of the graft being released. To ensure 
appropriate fluid management, various hemodynamic parameters are measured during 
the course of the operation. The most widely used parameter to assess intravascular 
volume is central venous pressure (CVP). Though this has been used for many years 
and is widely accepted by most anaesthesiologists and intensivists as a good indicator 
of intravascular volume, it has its limitations. Primarily it is based on certain 
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assumptions about the relationship between the pulmonary and systemic circulations 
and that pressure in the cardiac chambers reflects volume. This may not always be the 
case, particularly in patients undergoing intermittent positive pressure ventilation with 
positive end expiratory pressure. Renal transplants are invariably done under general 
anaesthesia and patients are on IPPV with PEEP. Secondly the use of central venous 
pressure may not be reliable when the patient’s position is changed during the operation. 
This too happens frequently during the course of the operation to facilitate better vision 
during the vascular anastomosis.  
 
Direct arterial pressure monitoring is routinely done during renal transplant 
surgery and with newer anaesthetic monitors with the facility to measure PPV; this 
parameter may be easily monitored in all patients. The primary advantage of PPV is that 
being a dynamic parameter it is unaffected by variations of intrathoracic pressure and 
patient position. It is recorded from a peripheral arterial canola and therefore does not 
require central venous access that may be associated with line sepsis considering the 
renal graft recipient is under immunosuppression.  
 
The aim of this study was to ascertain if there was a correlation between PPV 
and intravascular volume as measured indirectly by the time between reperfusion of the 
graft and onset of post transplant diuresis. Fluid balance was achieved and maintained 
by achieving and maintaining a target CVP of 10-15 mm of Hg. The PPV too was 
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monitored but there was no target value set and there was no intervention initiated 
based on the PPV value.  
 
It was found that neither CVP nor PPV had a correlation with time to urine output 
at the time of reperfusion of the renal graft. This could be due to various reasons. Firstly 
intravascular volume is only one factor that affects graft function. There are many other 
factors such as the surgical technique, the cold and warm ischaemia times and even the 
donor characteristics that were not considered in the analysis. Secondly time to urine 
output was used as a surrogate marker of adequacy of intravascular. Though it is 
known that the earlier post transplant diuresis begins, the better the outcome, it may not 
be an accurate marker of intravascular volume and cardiac output. 
 
Though the two values did not correlate, the ROC curve analysis revealed that if 
a certain target PPV could be achieved at the time of reperfusion of the renal graft, this 
was a reasonably good predictor of time to urine output as the specificity was as high as 
85% though the sensitivity was not higher than 50%. If a PPV of <10% could be 
achieved, there was a high likelihood of the time to urine output being less than 120 
seconds. Though it was also noted that a target PPV of < 8% there was a high 
likelihood of urine output in less than 60 seconds, this was disregarded as the number 
of patients falling into this category of urine output in less than 60 seconds was very 
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small (7 out of 33). Therefore it was inferred that the most suitable cut off was ≥10% 
which meant the target PPV to achieve would be <10%. 
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CONCLUSIONS 
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1. Though there is no apparent linear correlation between PPV and 
TUO, it could be used as a tool to predict the likelihood of time to 
urine output 
 
2. The best cut off value for PPV to achieve a urine output within 120 
seconds was <10%.  
 
 
In other words patients in whom a target PPV of <10% is achieved at 
the time of revascularization of the graft are likely to start producing 
urine in <120 seconds. 
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LIMITATIONS 
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• The sample size was small – only 33 patients. The planned sample size of 40 
could not be achieved. 
 
• The variables (CVP, PPV and Time to urine output) were not normally 
distributed. This could be due to the small sample size. 
 
• The primary outcome variable that was used was “Time to urine output”. This 
is not solely dependent on intravascular volume and there could have been 
other factors such as surgical technique and ischemia time that could affect 
this measurement. 
 
• Donor factors were not taken into account 
 
• This study did not look at early and delayed indicators of renal dysfunction 
which would be indicated by biochemical tests and glomerular filtration rates. 
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ANNEXURES 
Consent forms 
Proforma 
Anaesthesia protocol 
IRB minute 
 
CONSENT FORM 
 
Study Title: Correlation between Pulse Pressure Variation (PPV) and adequacy of intra-
vascular volume as reflected by time to urine output in renal transplant recipients  
 
 
Study Number: 
Participant’s name: 
Date of Birth / Age (in years): 
 
I__________________________________________________________________ , 
son/daughter of ______________________________________________________ 
declare that I have read the information sheet provided to me regarding this study and have 
clarified any doubts that I had. 
 
I also understand that my participation in this study is entirely voluntary and that I am free to 
withdraw permission to continue to participate at any time without affecting my usual treatment 
or my legal rights. 
 
I also understand that although I have to pay for the anesthetic drugs and equipment for the 
surgery. 
 
I understand that no study related injury or adverse event is expected since there is no 
intervention instituted and therefore any injury or adverse event encountered is considered that 
of routine anesthesia and that I will not receive compensation for such injury. 
 
I understand that the study staff and institutional ethics committee members will not need my 
permission to look at my health records even if I withdraw from the trial. I agree to this access. 
 
I understand that my identity will not be revealed in any information released to third parties or 
published. 
 
I voluntarily agree to take part in this study. 
 
Name of participant (or thumb impression): 
Signature: 
Date: 
 
Name of witness: 
Signature of witness: 
Relation to participant: 
Date: 
 
Name of investigator: 
Signature of investigator 
Date: 
 
Xg;ge;j gotk; 
 
Ma;tpd; jiyg;g[ : rpWePuf khw;W rpfpr;ir bgWk; nehahspfspd; eho 
mGj;jj;jpw;Fk;/ rpWePufk; btspapLk; neuj;jpw;Fk; ,ilna Vw;gLk; bjhlh;ig 
mwpa[k; Ma;t[. 
 
Ma;tpd; vz; : 
g';nfw;gthpd; bgah; : 
gpwe;j ehs; / taJ (Mz;Lfspy;) : 
 
ehd; __________________________________________________________ 
kfd; / kfs; _______________________________________________________ 
,e;j Ma;t[ gw;wpa jfty; mwpf;ifia vdf;F mspj;j jfty; jhs; _yk; 
bjhpe;Jf; bfhs;tnjhL kl;Lky;yhky; vdf;F Vw;gLk;; re;njf';fisa[k; 
epth;j;jp bra;J bfhs;syhk; vd mwpntd;. 
 
,e;j Ma;tpy; vd; g';F Kw;wpYk; jd;dhh;tKilanjhL/ ,e;j Ma;tpy; ehd; 
g';nfw;gjpdhny / tpyfpdhnyh ve;;neuj;jpYk; vd; tHf;fkhd rpfpr;ir 
my;yJ vd; rl;l chpikfs; ghjpf;fhJ vd ehd; mwpntd;. 
 
mWit rpfpr;irf;F njitahd cgfuz';fs; kw;Wk; kaf;f kUe;Jfs; 
bfhLf;fg;gl ntz;Lk; vd;gjida[k; ehd; mwpntd;. 
 
,e;j Ma;t[ rhh;e;j fhak; my;yJ vjph;tpist[fs; Vw;gl;lhy; mjw;F 
epWtdk; bghWg;ngw;fhJ vdt[k;/ ,jd; tpisthf Vw;gl;l ve;j fhak; 
my;yJ vjph;tpist[f;F tHf;fkhd kaf;f kUe;J gad;gLj;jyhk; vd 
fUjg;gLfpwJ.  ,f;fhaj;jpw;fhd ,Hg;gPL VJk; bgw KoahJ vd;gij ehd; 
mwpntd;. 
 
ehd; ,e;j Ma;tpy; ,Ue;J tpyfpf; bfhz;lhnyh vd; Rfhjhu gjpt[fis 
ghh;f;f Ma;t[ CHpah;fs; kw;Wk; epWtd bewpKiw FG cWg;gpdh;fSf;F vd; 
mDkjp njitapy;iy vd;gjid ehd; xg;g[f; bfhs;fpnwd;.   
 
vd;id gw;wpa Ma;tp[d; tptu';fis _d;whk; eghplk; btspaplkhl;Oh;fs; 
vd;gij ehd; mwpntd;. 
 
ehnd Kd; te;J ,e;j Ma;tpy; g';nfw;f xg;g[f;bfhs;fpnwd;. 
 
  
g';nfw;gthpd; bgah; (bgUtpuy; milahsk;) : 
ifbaGj;J : 
njjp : 
 
rhl;rpahsh; bgah; : 
rhl;rpahshpd; ifbahg;gk; : 
g';nfw;gthpd; cwt[Kiw : 
njjp : 
 
Ma;thshpd; bgah; : 
Ma;thshpd; ifbahg;gk; : 
njjp : 
fpUj;Jt kUj;Jt fy;Y]hp/ ntY]h; 
kaf;f kUe;jpay; epg[zh; Jiw 
nehahspapd; jfty; jhs; 
Ma;tpd; jiyg;g[ : rpWePuf khw;W rpfpr;ir bgWk; nehahspfspd; eho 
mGj;jj;jpw;Fk;/ rpWePufk; btspapLk; neuj;jpw;Fk; ,ilna Vw;gLk; bjhlh;ig 
mwpa[k; Ma;t[. 
 
c';fs; ,lkhw;wg;gl;l rpWePuf bray;ghl;il ,uj;j mGj;jk; bjhlh;g[ 
rhpghh;f;fpwJ vd;W xU Ma;tpy; g';nfw;f nfl;L bfhs;sg;gLfpwhh;fs;. 
 
,e;j Ma;tpd; nghJ vd;d bra;a ntz;Lk;? 
c';fSf;F xU rpWePuf khw;W mWit rpfpr;ir bra;a nghfpnwhk;.  bghJthf/ 
,e;j eltof;ifapd; nghJ bjhlh;e;J c';fs; ,uj;j mGj;jk; fz;fhzpf;f 
nghfpnwhk;.  c';fs; clypy; ,uz;L ,uj;j ehs';fs; cs;sd/ jkdpfs; 
(clypd; kw;w cWg;g[fSf;F c';fs; ,jaj;jpy; ,Ue;J ,uj;jj;ij vLj;J 
bry;Yk;) kw;Wk; rpiufs; (,jaj;jpw;F kPz;Lk; ,uj;jk; vLj;Jr; bry;Yk;).  
,e;j ,uz;L ,uj;j mGj;jk; msf;fg;gLk;.  ,J c';fs; ifapy;/ c';fs; 
fGj;jpy; cly; toFHha; (fbdby) gad;gLj;jp bra;ag;gLfpwJ.  
,lkhw;wg;gl;l rpWePufk; rpWePiu cw;gj;jp bra;a bjhl';Fk; neuj;ij 
mstpLnthk;.  ehk; ,lkhw;wg;gl;l rpWePuf bray;ghl;il rpwg;ghf 
bray;gLj;j ,e;j ,uz;L mGj;j kjpg;g[fs; fz;Lgpof;f ,e;j mstPLfs; 
gad;gLj;jg;gLfpwJ. 
 
,jpy; g';nfw;gtUf;F gzk; brythFkh? 
,e;j eltof;ifapd; nghJ ve;j TLjy; bray;Kiwfs; epfH;j;j 
nghtjpy;iy. Mifahy; ,e;j nrhjidapy; g';nfw;gtUf;F ve;j gzKk; 
brythfhJ. 
 
,e;j Ma;tpy; g';nfw;gtUf;F VnjDk; Cjpak; bfhLf;f ntz;Lkh? 
,e;j Ma;tpy; g';nfw;ghdJ jd;dpiyahdJ.  Mjyhy; jh';fs; ve;j tpj 
Cf;f Cjpak; bfhLf;f ntz;oajpy;iy. 
 
ehd; ,e;j Ma;tpy; g';nfw;ftpy;iy vd;why; vd;d bra;tPh;fs;? 
eP';fs; ,e;j Ma;tpy; g';nfw;whnyh / ,y;iy vd;whnyh c';fSf;F 
tHf;fkhd guhkhpg;g[ bjhlUk;. 
 
 
eh';fs; Muk;gj;jpy; g';nfw;f xg;g[f; bfhz;l gpd;dh;/  vd; kdij khw;w 
Kot[ bra;jhy;? 
eP';fs; ve;j neuj;jpYk; ,e;j Ma;tpy; ,Ue;J tpyfp bfhs;s neh;e;jhYk; mJ 
c';fspd; tHf;fkhd rpfpr;ir Kiwapy; vt;tpj ghjpg;g[k; ,Uf;fhJ. 
 
,e;j Ma;tpy; vdf;F vd;d gad;? 
,e;j Ma;tpypUe;J ve;j neuo ed;ika[k; ,y;iy.  ,e;j ,uj;j mGj;j 
mstpl;il fz;fhzpg;gjd; _yk; kw;w rpWePuf khw;W mWit rpfpr;ir 
bra;ag; nghFk; nehahspfSf;F gad;gLk;. 
 
,e;j Ma;tpy; ahh; jfty; mQf ntz;Lk;? 
Muha;r;rpahsh;fs; kl;Lnk Ma;t[ bjhlh;ghd jftiy mQf Koa[k;.  
midj;J jfty;fSk; ufrpakhf itf;fg;gLk;. 
 
ehd; TLjy; nfs;tpfs; nfl;f ntz;Lk; vd;why; ahhplk; bjhlh;g[ bfhs;s 
ntz;Lk;? 
c';fSf;F VnjDk; re;njfk; ,Ue;jhy; vg;nghJ ntz;LkhdhYk;                
Dr. Y. bgh;dp!; jpnahlh;/ 9486843882 vd;gtiu mQfyhk;. 
 
 
Date:                                                                    Comparison of PPV and CVP in Renal Transplant                                                              Sl.#	
DEMOGRAPHIC
NAME
Hosp. No.
AGE
WEIGHT
Gender M F
HEIGHT
Duration 
( years)
Medication
HTN Y / N
DM Y / N
IHD Y / N
Echo RWMA Y / N
Ejection 
Fraction
%
Transplant Recipient  characteristics and lab values
Duration of 
CKD (years)
HD Y/N
Peritoneal 
dialysis
Y/N
Duration of HD 
(months)
Last HD/PD 
(hours)
Pre HD/PD 
weight (Kg)
Post HD/PD 
weight (Kg)
Total weight 
loss/gain
Electrolytes
Post HD
sodium Potassium Bicarbonate Calcium
Pre Op Hb
Pre Op 
Creatinine
Co Morbid Diseases
Study Protocol
Activate PPV in OR 4 monitor, Set to Screen D
Induction:
	 Propofol 2mg/Kg
	 Fentanyl 2 mcg/Kg
	 Rocuronium 0.1mg/Kg
Arterial Line under sterile condition
Triple lumen IJV with ultrasound
Collect data q15mins- set to ALL
Clamp release to first urine:- time in seconds
Total urine output till recovery room
Patient Sticker
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q15mins
Time
         :         am Heart Rate SBP DBP MAP CVP PPV Tidal Volume
Peak 
Inspiratory 
Pressure
PEEP
Pre Induction
T1(after CVP)
T2
T3
T4
T5
T6
T7
T8
T9
T10
T11
T12
T13
T14
T15
T16
Just Prior to 
Venous clamp 
release
At first Urine 
Output
At extubation
: - - - - -
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
:
Clamp release to onset of urine formation in 
Recipient                                        min:sec
Turgidity            I                     II                       III
Hemodynamic Monitoring
Patient Sticker
Turgidity score I (soft graft), score II (moderately turgid graft), and score III (highly turgid and firm graft)
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Kidney Donor Characteristics
Age of Donor
Height of Donor cm
Weight of Donor Kg
Co morbidity Hypertension  Y / N
DM  Y / N
Open Donor Nephrectomy  Y / N
Laparoscopic Donor Nephrectomy  Y / N
Warm Ischemia Time        min:sec
Cold Ischemia Time           min:sec
Total fluids to donor           ml
Fluid Balance
Intake Crystalloids milliLiters
NS
RL
Blood transfused
Output Total urine till recovery room
Blood Loss
Total 
Ephedrine
Adrenaline
Dopamine
Nor 
Adrenaline
Furosemide
Mannitol
mg
mcg
mcg
mcg
mg
g
Intake Output measure
Intra Operative Vasoactive Drugs
post induct pre re perfusion post re perfusion
ABG VBG ABG VBG ABG VBG
pH
CO2
O2
HCO3
BE
Lac
Na
K
Cl
Ca
Hb
SpO2
Patient Sticker
ANAESTHESIA PROTOCOL FOR RENAL TRANSPLANTATION  
FOR STUDY COMPARING CVP AND PPV 
 
Pre-induction Checklist 
Creatinine and Electrolytes (Na,K,HCO3) after last dialysis 
Weight loss after last dialysis 
 
Monitors – ECG, SaO2, NIBP, ABP, EtCO2, Temperature, CVP, MAC, PPV 
 
Warming devices 
Level 2 fluid warmer 
Bair hugger 
 
Induction 
Fentanyl 2mcg/Kg IV 
Propofol 2mg/Kg IV 
Rocuronium 1mg/Kg IV 
Intubation using appropriate sized tube 
Antibiotics as per surgeons’ preference 
 
Insert and secure ABP cannula (radial artery on the hand without the AV fistula)  
Insert CVP cannula under ultrasound guidance. Scan both IJV before selecvting one. After guide wire 
insertion, please correct location using ultrasound. 
 
Maintenance  
O2+Air+Isoflurane 
Morphine 0.15mg / Kg just prior to incision 
Methylprednisolone 1g IV 
IV fluids – Ringer Lactate 15-30 ml/Kg/hr 
 
Haemodynamic monitoring and managemnt 
Target CVP > 12-15 mm Hg  
Maintain MAP ≥ 90 mm Hg 
Maintain SBP ≥ 120 mm Hg 
Mannitol 0.5 mg/Kg IV over 30 mins, when the donor kidney is brought into the OR 
ABG at the end of venous anastomosis 
Furosemide 1mg/kg, IV during second half of arterial anastomosis 
Ephedrine 5-10 mg at the end of arterial anastomosis 
Adrenaline 5-10 mcg just prior to release of Satinsky clamp from the External Iliac vein 
 
Reversal 
Neostigmine and Glycopyrolate given at the time of closure of muscle layer. 
Change to PSVPro at pressure support of 10 cm 
Titrate Morphine to maintain respiratory rate of > 15-20/min 
 
Urine 
Record the urine produced till recovery 
 
 
 


